Formycon Begins Biosimilar Ustekinumab Trial

Phase I Trial Announcement Comes Shortly After NeuClone

 
• By David Wallace
Race_Track
Formycon’s Phase I trial has got off the blocks at around the same time as NeuClone’s • Source: Shutterstock

More from Biosimilars

More from Products